University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$4.43M |
| 2 |
Enterprise Products Partners
EPD
|
+$3.49M |
| 3 |
Energy Transfer Partners
ET
|
+$2.42M |
| 4 |
Kinder Morgan
KMI
|
+$2.27M |
| 5 |
TC Energy
TRP
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$77.4K |
| 2 |
United Therapeutics
UTHR
|
+$40K |
| 3 |
Abbott
ABT
|
+$22.3K |
| 4 |
Regions Financial
RF
|
+$5K |
| 5 |
Huntington Bancshares
HBAN
|
+$5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 23.96% |
| 2 | Technology | 3.7% |
| 3 | Healthcare | 3.37% |
| 4 | Consumer Discretionary | 0.23% |
| 5 | Industrials | 0.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Costco
COST
$423B
| $10K | 0.01% |
+50
| New | +$11.2K |
|
52
Global Payments
GPN
$24B
| $10K | 0.01% |
+101
| New | +$11.1K |
|
53
Paychex
PAYX
$43.3B
| $10K | 0.01% |
+151
| New | +$10.2K |
|
54
PepsiCo
PEP
$192B
| $9K | 0.01% |
+77
| New | +$8.68K |
|
55
Procter & Gamble
PG
$337B
| $7K | 0.01% |
+81
| New | +$7.24K |
|
56
Apple
AAPL
$4.45T
| $6K | 0.01% |
+160
| New | +$7.76K |
|
57
Portland General Electric
POR
$5.92B
| $5K | 0.01% |
118
| – | – |
|
58
Vanguard Health Care ETF
VHT
$19.1B
| $3K | ﹤0.01% |
+20
| New | +$3.39K |
|
|
59
Abbott
ABT
$193B
| $2K | ﹤0.01% |
25
-318
| -93% | -$22.3K |
|
|
NBL
60
DELISTED
Noble Energy, Inc.
NBL
| $2K | ﹤0.01% |
+100
| New | +$2.56K |
|
61
IBM
IBM
$222B
| $1K | ﹤0.01% |
+10
| New | +$1.2K |
|
|
62
Huntington Bancshares
HBAN
$36.1B
| – | – |
-335
| Closed | -$5K |
|
|
63
Regions Financial
RF
$27B
| – | – |
-270
| Closed | -$5K |
|
|
64
United Therapeutics
UTHR
$21.7B
| – | – |
-315
| Closed | -$40K |
|
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q4 2018 Portfolio in Review
As of Q4 2018, University of Texas/Texas AM Investment Management Co (UTIMCO) held 64 positions worth $92.6M, up 14% from $80.9M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $25.9M of net new capital in Q4 2018, opening 44 new positions and adding to 2 existing holdings. Its largest new stake was Enbridge: 137,838 shares worth $4.28M.
By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 0.06% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $77.4K trimmed.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q4 2018 buy was Enbridge: 137,838 shares worth $4.28M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to AbbVie in Q4 2018, an estimated $73.3K increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q4 2018 reduction was Texas Instruments, cutting an estimated $77.4K.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited United Therapeutics in Q4 2018, selling an estimated $40K.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 83% of its $92.6M portfolio in Q4 2018.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 44 new positions and closed 3 in Q4 2018.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 14% quarter-over-quarter to $92.6M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2018, filed 14 Feb 2019.